Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
Authors: Pönisch W; Department of Hematology and Oncology, University of Leipzig, Johannisallee 32A, 04103 Leipzig, Germany. Wolfram.Poenisch@medizin.uni-leipzig.de, Bourgeois M, Moll B, Heyn S, Jäkel N, Wagner I, Rohrberg R, Hurtz HJ, Schmalfeld M, Aßmann M, Edelmann T, Mohren M, Hoffmann FA, Becker C, Schwarzer A, Schönfelder U, Zehrfeld T, Hensel G, Löschcke K, Krahl R, Ali HA, Niederwieser D
Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2013 Mar; Vol. 139 (3), pp. 499-508. Date of Electronic Publication: 2012 Nov 25.
Publication Type: Evaluation Study; Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1335
DOI:10.1007/s00432-012-1339-3